Biofil Chemicals (India) Today
| BIOFILCHEM | 61.91 0.24 0.39% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Biofil Chemicals is trading at 61.91 as of the 28th of November 2024, a 0.39 percent decrease since the beginning of the trading day. The stock's open price was 62.15. Biofil Chemicals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Biofil Chemicals Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Biofil Chemicals is entity of India. It is traded as Stock on NSE exchange. The company has 16.27 M outstanding shares. More on Biofil Chemicals Pharmaceuticals
Moving together with Biofil Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Biofil Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biofil Chemicals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biofil Chemicals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Chairman | Ramesh Shah | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Chemicals Makers, Synthetics, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Health Care (View all Sectors) | ||||
Biofil Chemicals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biofil Chemicals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBiofil Chemicals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biofil Chemicals' financial leverage. It provides some insight into what part of Biofil Chemicals' total assets is financed by creditors.
| |||||
Biofil Chemicals Pharmaceuticals (BIOFILCHEM) is traded on National Stock Exchange of India in India and employs 26 people. Biofil Chemicals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biofil Chemicals's market, we take the total number of its shares issued and multiply it by Biofil Chemicals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biofil Chemicals Pha operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 16.27 M outstanding shares.
Biofil Chemicals Pharmaceuticals has accumulated about 260 K in cash with 23.94 M of positive cash flow from operations.
Check Biofil Chemicals Probability Of Bankruptcy
Ownership AllocationBiofil Chemicals holds a total of 16.27 Million outstanding shares. Biofil Chemicals Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biofil Ownership Details
Biofil Chemicals Pha Risk Profiles
Although Biofil Chemicals' alpha and beta are two of the key measurements used to evaluate Biofil Chemicals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.68 | |||
| Standard Deviation | 4.12 | |||
| Variance | 16.98 | |||
| Risk Adjusted Performance | 0.0047 |
Biofil Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biofil Chemicals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Biofil Chemicals Corporate Management
Elected by the shareholders, the Biofil Chemicals' board of directors comprises two types of representatives: Biofil Chemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biofil. The board's role is to monitor Biofil Chemicals' management team and ensure that shareholders' interests are well served. Biofil Chemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biofil Chemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pavan Rajput | Chief Officer | Profile | |
| Anisha Mangal | Company Secretary | Profile | |
| Joseph Chacko | Head Administration | Profile | |
| Akshay Atri | Marketing Manager | Profile | |
| Shweta Verma | Company officer | Profile | |
| Vinayak Bhopte | Chief Chemist | Profile | |
| Shikha Khilwani | Company Officer | Profile |
Other Information on Investing in Biofil Stock
Biofil Chemicals financial ratios help investors to determine whether Biofil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biofil with respect to the benefits of owning Biofil Chemicals security.